Targeting PKCθ in skeletal muscle and muscle diseases: good or bad?
about
Disease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase Cα and Protein Kinase CβPharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study.
P2860
Targeting PKCθ in skeletal muscle and muscle diseases: good or bad?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Targeting PKCθ in skeletal muscle and muscle diseases: good or bad?
@en
type
label
Targeting PKCθ in skeletal muscle and muscle diseases: good or bad?
@en
prefLabel
Targeting PKCθ in skeletal muscle and muscle diseases: good or bad?
@en
P2860
P50
P356
P1476
Targeting PKCθ in skeletal muscle and muscle diseases: good or bad?
@en
P2093
Piera Fiore
Valeria Marrocco
P2860
P304
P356
10.1042/BST20140207
P577
2014-12-01T00:00:00Z